Global Network

Purdue and a network of independent associated companies (including the Mundipharma and Napp companies) have a presence in more than 30 countries and the collective strength of more than 5000 employees worldwide. This global network has distribution capabilities in all key markets. Each company within the network is a leader in their respective markets for key therapeutic areas. When you partner with Purdue, a product has true potential for a broad global reach.

Global Network

Global Network

For more information on Purdue’s global network and other reasons to partner with Purdue, contact the Licensing & Business Development Team.

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.